Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1I2 | O75469 | 1/20 | 1.00 |
| ▸ | NR3C1 | P04150 | 1/20 | 1.00 |
| ▸ | HTR1A | P08908 | 1/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 1.00 |
| ▸ | CNR1 | P21554 | 1/20 | 1.00 |
| ▸ | TBXA2R | P21731 | 1/20 | 1.00 |
| ▸ | SLC6A2 | P23975 | 1/20 | 1.00 |
| ▸ | HTR2A | P28223 | 1/20 | 1.00 |
| ▸ | HTR2C | P28335 | 1/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 1/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 1/20 | 1.00 |
| ▸ | OPRK1 | P41145 | 1/20 | 1.00 |
| ▸ | HTR2B | P41595 | 1/20 | 1.00 |
| ▸ | PDE4D | Q08499 | 1/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 1/20 | 1.00 |
| ▸ | ADRB2 | P07550 | 10/20 | 0.53 |
| ▸ | ADRB1 | P08588 | 10/20 | 0.53 |
| ▸ | ADRB3 | P13945 | 10/20 | 0.53 |
| ▸ | SGMS2 | Q8NHU3 | 1/20 | 0.51 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Croconazole SCHEMBL7601955 | 1.00 | NR1I2 (1.00) | NR1I2NR3C1HTR1AADORA3CNR1 | |
| Croconazole SCHEMBL29378466 | 1.00 | NR1I2 (1.00) | NR1I2NR3C1HTR1AADORA3CNR1 | |
| Croconazole SCHEMBL36790 | 0.99 | NR1I2 (0.98) | NR1I2NR3C1HTR1AADORA3CNR1 | |
| Croconazole SCHEMBL121863 | 0.99 | NR1I2 (0.98) | NR1I2NR3C1HTR1AADORA3CNR1 | |
| Croconazole SCHEMBL1274172 | 0.93 | NR1I2 (0.86) | NR1I2NR3C1HTR1AADORA3CNR1 | |
| Croconazole SCHEMBL3690346 | 0.92 | NR1I2 (0.85) | NR1I2NR3C1HTR1AADORA3CNR1 | |
| SCHEMBL11090539 | 0.87 | NR1I2 (0.78) | NR1I2NR3C1HTR1AADORA3CNR1 | |
| SCHEMBL2449293 | 0.84 | HTR1A (0.73) | NR1I2NR3C1HTR1AADORA3CNR1 | |
| SCHEMBL2449294 | 0.84 | HTR1A (0.73) | NR1I2NR3C1HTR1AADORA3CNR1 | |
| SCHEMBL9662402 | 0.83 | NR1I2 (0.72) | NR1I2NR3C1HTR1AADORA3CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4215 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12274830-B2 | Nitric oxide inhalation therapy for infants with bronchiolitis | BEYOND AIR LTD (IL) | 2025-04-15 | — | — | US | claimed |
| US-20250099557-A1 | ANTIBIOTIC PHARMACEUTICAL COMPOSITION CAPABLE OF SUBCUTANEOUS ADMINISTRATION | SHANGHAI BAO PHARMACEUTICALS CO., LTD. (CN) | 2025-03-27 | — | — | US | claimed |
| US-20250017904-A1 | ANTIMICROBIAL COMPOSITIONS CONTAINING A SYNERGISTIC COMBINATION OF ACTIVATED CREATININE AND AN IMIDAZOLE ANTIFUNGAL AGENT | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) | 2025-01-16 | — | — | US | claimed |
| WO-2024235510-A1 | ANTI-DANDRUFF COMPOSITIONS | ANALYTICON DISCOVERY GMBH (DE) | 2024-11-21 | — | — | WO | claimed |
| EP-4464309-A1 | ANTIDANDRUFF COMPOSITION COMPRISING 1-ACETOXYCHAVICOL ACETATE | Analyticon Discovery GmbH (DE) | 2024-11-20 | — | — | EP | claimed |
| US-20240173512-A1 | METHODS FOR POTENTIATING ANTIMICROBIAL AGENTS | STREETERVILLE CAPITAL, LLC | 2024-05-30 | — | — | US | claimed |
| EP-4374848-A1 | ANTIBIOTIC PHARMACEUTICAL COMPOSITION CAPABLE OF SUBCUTANEOUS ADMINISTRATION | Shanghai Bao Pharmaceuticals Co., Ltd. (CN) | 2024-05-29 | — | — | EP | claimed |
| WO-2024046311-A1 | COMPOSITION USED FOR KILLING FUNGI AND METHOD FOR APPLYING COMPOSITION | 江苏中旗科技股份有限公司 | 2024-03-07 | — | — | WO | claimed |
| US-11890421-B2 | Methods for potentiating antimicrobial agents | BEYOND AIR LTD (IL) | 2024-02-06 | — | — | US | claimed |
| US-20230233483-A1 | COMPOUND AND METHOD FOR THE TREATMENT OF CORONAVIRUSES | APTEEUS (FR) | 2023-07-27 | — | — | US | claimed |
| US-5374633-A | Mixtures of nitrogen-heterocyclic antifungal compounds, fatty acid esters, propylene glycol and drugs, for increasing dosage by promoting absorption | BRISTOL-MYERS SQUIBB COMPANY (US) | 1994-12-20 | — | — | US | claimed |
| US-5214046-A | Synergistic mixtures, inhibitors of sterol biosynthesis | HOFFMANN-LA ROCHE INC. (US) | 1993-05-25 | — | — | US | claimed |
| EP-0538442-A1 | METHOD FOR IMPROVING THE THERAPEUTIC EFFICIENCY OF LIPOSOLUBLE ANTIFUNGAL AGENTS FROM THE IMIDAZOLE FAMILY, AND COMPOSITION FOR IMPLEMENTING SAME. | OREAL (FR) | 1993-04-28 | — | — | EP | claimed |
| WO-1992019225-A1 | METHOD FOR IMPROVING THE THERAPEUTIC EFFICIENCY OF LIPOSOLUBLE ANTIFUNGAL AGENTS FROM THE IMIDAZOLE FAMILY, AND COMPOSITION FOR IMPLEMENTING SAME | L'OREAL (FR) | 1992-11-12 | — | — | WO | claimed |
| EP-0457333-A2 | Topical composition | Bristol-Myers Squibb Company (US) | 1991-11-21 | — | — | EP | claimed |
| EP-0310122-B1 | ANTIFUNGAL COMPOSITION | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 1991-07-24 | — | — | EP | claimed |
| EP-0319965-B1 | PHARMACEUTICAL PREPARATION FOR TINEA PEDIS | SHIONOGI SEIYAKU KABUSHIKI KAISHA (JP) | 1991-03-13 | — | — | EP | claimed |
| EP-0310122-A1 | Antifungal composition | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 1989-04-05 | — | — | EP | claimed |
| US-4483866-A | FUNGICIDE | SHIONOGI & CO., LTD. (JP) | 1984-11-20 | — | — | US | claimed |
| US-4328348-A | Novel benzylimidazole derivatives | SHIONOGI & CO., LTD. (JP) | 1982-05-04 | — | — | US | claimed |